lipoxin a4 has been researched along with Cerebral Malaria in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aliberti, J; Costa, FT; Janes, S; McBerry, C; Salazar Gonzalez, RM; Shryock, N | 1 |
Antunes, B; Candéa, AP; Caruso-Neves, C; Carvalho, L; Estato, V; Henriques, MG; Maramaldo, T; Pádua, TA; Penido, C; Pinheiro, AA; Seito, LN; Silva, L; Souza Costa, MF; Souza, MC; Tibiriçá, E; Torres, ND | 1 |
2 other study(ies) available for lipoxin a4 and Cerebral Malaria
Article | Year |
---|---|
Lipoxin A₄ and 15-epi-lipoxin A₄ protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brain.
Topics: Animals; Arachidonate 5-Lipoxygenase; Brain; Interferon-gamma; Interleukin-12; Lipoxins; Malaria, Cerebral; Mice; Plasmodium berghei | 2013 |
Lipoxin A4 attenuates endothelial dysfunction during experimental cerebral malaria.
Topics: Animals; Brain; Cell Line; Disease Models, Animal; Endothelial Cells; Heme Oxygenase-1; Intercellular Adhesion Molecule-1; Lipoxins; Malaria, Cerebral; Male; Membrane Proteins; Mice, Inbred C57BL; Plasmodium berghei; Tumor Necrosis Factor-alpha | 2015 |